caba: the income statement

MyFinsight

Cabaletta Bio, Inc. (CABA)

For the quarter ending 2025-06-30, CABA made $1,411K in revenue. -$45,127K in net income. Net profit margin of -3198.23%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Net unrealized gain (loss) on available-for-sale investments, net of tax	1
Other expense	-61
Research and development	37,638
General and administrative	8,268
Total operating expenses	45,906
Loss from operations	-45,906
Interest income	1,410
Interest expense	571
Net loss	-45,128
Net comprehensive loss	-45,127

Net loss per share, basic	-0.73
Net loss per share, diluted	-0.73

Unit: Thousand (K) dollars (except for numbers of shares and EPS)